Sex differences in dopamine binding and modafinil conditioned place preference in mice

Drug and Alcohol Dependence
Rick E BernardiAnita C Hansson

Abstract

Studies in humans and rodents have demonstrated under certain conditions some reinforcing properties of modafinil, a drug being examined clinically for its potential to treat psychostimulant abuse. However, the majority of rodent studies examining the abuse potential of modafinil have used high doses that may not be clinically relevant. In fact, recent work has indicated that doses similar to those administered to humans are not reinforcing in mice. The current study examined sex differences in the ability of low-dose modafinil (0.75mg/kg, IP) to induce a conditioned place preference in mice, and assessed sex-dependent alterations in dopamine D1, D2 and DAT binding sites in reward-related regions in naïve and modafinil-treated mice. Low-dose modafinil failed to induce a conditioned place preference in male mice, while female mice demonstrated a significant modafinil place preference. Several dopamine binding differences were also detected in naïve and modafinil-treated mice, including sex differences in D1 and D2 availability in reward-related regions, and are discussed in relation to sex-dependent differences in the reinforcing effects of modafinil and psychostimulants in general. These findings implicate sex differences in th...Continue Reading

References

Jul 1, 1993·Neuroendocrinology·M Morissette, T Di Paolo
Jun 24, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·T H LeeE H Ellinwood
Feb 9, 2000·Psychopharmacology·W J Lynch, M E Carroll
Sep 5, 2001·The American Journal of Psychiatry·L H MozleyR E Gur
May 1, 2002·Behavioural Pharmacology·C R RushA F Wooten
Jun 14, 2002·Pharmacology, Biochemistry, and Behavior·Charles W Schindler, Gilberto N Carmona
Jun 18, 2002·European Journal of Pharmacology·Charles W SchindlerEric B Thorndike
Jun 20, 2002·Psychopharmacology·V Deroche-GamonetP V Piazza
Jul 20, 2002·Drug and Alcohol Dependence·Craig R RushAdam F Wooten
Apr 23, 2003·Brain Research·Scott J RussoVanya Quinones-Jenab
Jun 16, 2004·Brain Research Bulletin·Arbi NazarianVanya Quinones-Jenab
Jul 15, 2004·Pharmacology, Biochemistry, and Behavior·Steven B HarrodRosemarie M Booze
Nov 5, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Charles A DackisCharles P O'Brien
Aug 4, 2006·The Journal of Pharmacology and Experimental Therapeutics·Bertha K MadrasAlan J Fischman
Oct 2, 2007·Frontiers in Neuroendocrinology·Jill B Becker, Ming Hu
Nov 27, 2008·Pharmacology, Biochemistry, and Behavior·Elena ZakharovaSari Izenwasser
Feb 7, 2009·The Journal of Pharmacology and Experimental Therapeutics·Dorota ZolkowskaMichael H Baumann
Mar 19, 2009·JAMA : the Journal of the American Medical Association·Nora D VolkowKaren Apelskog-Torres
Apr 1, 2009·Behavioral Neuroscience·Tristan ShumanStephan G Anagnostaras
Jun 2, 2009·Behavioural Brain Research·Rick E BernardiS Paul Berger
Jun 30, 2009·Drug and Alcohol Dependence·Ann L AndersonAhmed M Elkashef
Sep 29, 2009·Drug and Alcohol Dependence·Suzanne K VosburgRichard W Foltin
Mar 31, 2010·Psychopharmacology·Carmela M Reichel, Ronald E See
Apr 14, 2010·Psychopharmacology·Monica L AndersenLeonard L Howell
Apr 27, 2010·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Dimitris RepantisIsabella Heuser
Sep 21, 2010·Brain Research Bulletin·Samara A Morris BobzeanLinda I Perrotti
Oct 14, 2010·Experimental and Clinical Psychopharmacology·Jennifer L NewmanNancy K Mello
Dec 16, 2010·Synapse·Thi-Lien NguyenChoon-Gon Jang
Mar 18, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jared W YoungMark A Geyer
Jul 8, 2011·The International Journal of Neuropsychopharmacology·Carmela M Reichel, Ronald E See
Jul 12, 2011·Nature Neuroscience·Estefanía P BelloMarcelo Rubinstein
Jul 28, 2011·Addiction Biology·Raphael Wuo-SilvaRoberto Frussa-Filho
Aug 9, 2011·Drug and Alcohol Dependence·Nathan A HoltzMarilyn E Carroll

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here